{"schema_version":"secwatch.filing_event.v1","accession":"0001522767-24-000005","form_type":"8-K","ticker":"MRMD","cik":"0001522767","company_name":"MARIMED INC.","filed_at":"2024-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.484886+00:00","generated_at":"2026-06-05T02:35:52.621082+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"MariMed Q4 revenue $38.9M (+8.6% YoY); GAAP net loss $10.1M; announces MD dispensary acquisition","bullets":["Q4 2023 revenue $38.9M, up 8.6% from $35.8M in Q4 2022; full year revenue $148.6M, up 10.9% from $134.0M.","GAAP net loss of $10.1M in Q4 vs net income of $4.8M in prior year; full year net loss $16.0M vs net income $13.6M.","Non-GAAP adjusted EBITDA $5.2M in Q4 (14% margin) vs $4.5M in Q4 2022; full year $24.7M (17% margin) vs $32.4M (24% margin).","Company announces pending acquisition of a dispensary in Upper Marlboro, Maryland, expanding its footprint in the state.","CEO cites sixth consecutive year of double-digit revenue growth and positive adjusted EBITDA; wholesale operations in Illinois contributing to 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001522767-24-000005","json":"https://secwatch.observer/filing/0001522767-24-000005.json","markdown":"https://secwatch.observer/filing/0001522767-24-000005.md","text":"https://secwatch.observer/filing/0001522767-24-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1522767/000152276724000005/0001522767-24-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1522767/000152276724000005/mrmd-20240306.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T02:35:52.621082+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ef5f6bd0bb26ef48cfbb93ac03d0b1581286ddbe","claim":"MARIMED INC. reported financial results for the fourth quarter and year ended December 31, 2023.","evidence_excerpt":"On March 6, 2024, MariMed Inc. (the “Company”) issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference, announcing its financial results for the three months and year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1522767/000152276724000005/0001522767-24-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}